A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms
Clinical trial NCT01704963 · COMPLETED
Trial details
- NCT number
- NCT01704963
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-12
- Primary completion
- 2015-11-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.